title: An update on allogeneic hematopoietic progenitor cell transplantation for myeloproliferative neoplasms in the era of tyrosine kinase inhibitors.
abstract: Myeloproliferative neoplasms are a category of diseases that have been traditionally amenable to allogeneic hematopoietic progenitor cell transplantation. Current developments in drug therapy have delayed transplantation for more advanced phases of the disease, especially for patients with CML, whereas transplantation remains a mainstream treatment modality for patients with advanced myelofibrosis and chronic myelomonocytic leukemia. Reduced-intensity conditioning has decreased the treatment-related mortality, and advances in the use of alternative donors for transplantation could extend the use of this procedure to an increasing number of patients with improved safety and efficacy. Here we review the current knowledge about allogeneic transplantation for myeloproliferative neoplasms and discuss the most important aspects to be considered when contemplating transplantation for patients with these diseases. Janus kinase 2 inhibitors offer the promise to improve spleen size and performance of patients with myelofibrosis and extend transplantation for patients with more advanced disease.
authors.affiliation: Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authors.forename: K
authors.initials: K
authors.lastname: Adekola
authors.affiliation: Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authors.forename: U
authors.initials: U
authors.lastname: Popat
authors.affiliation: Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authors.forename: S O
authors.initials: SO
authors.lastname: Ciurea
mesh_terms: D064591:Allografts; D019337:Hematologic Neoplasms / Q000201:enzymology / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D053614:Janus Kinase 2 / Q000037:antagonists & inhibitors; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000201:enzymology / Q000628:therapy*; D009363:Neoplasm Proteins / Q000037:antagonists & inhibitors / Q000378:metabolism; D055728:Primary Myelofibrosis / Q000201:enzymology / Q000628:therapy*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D019172:Transplantation Conditioning / Q000379:methods*
chemical_list: D009363:Neoplasm Proteins; D047428:Protein Kinase Inhibitors; C507924:JAK2 protein, human; D053614:Janus Kinase 2
references.citation: Biol Blood Marrow Transplant. 2010 Mar;16(3):358-67
references.pmid: 19879949
references.citation: Biol Blood Marrow Transplant. 2007 Mar;13(3):355-65
references.pmid: 17317589
references.citation: Blood. 2012 Mar 15;119(11):2657-64
references.pmid: 22234678
references.citation: Br J Haematol. 2002 Jul;118(1):67-73
references.pmid: 12100129
references.citation: Blood. 2008 Oct 15;112(8):3500-7
references.pmid: 18664621
references.citation: Semin Hematol. 2010 Oct;47(4):354-61
references.pmid: 20875552
references.citation: Blood. 2010 Nov 4;116(18):3572-81
references.pmid: 20489052
references.citation: Br J Haematol. 2001 Feb;112(2):392-6
references.pmid: 11167837
references.citation: Br J Haematol. 2000 Jul;110(1):217-22
references.pmid: 10931002
references.citation: Br J Haematol. 2007 Jun;137(5):461-7
references.pmid: 17459051
references.citation: Blood. 2009 Dec 17;114(26):5264-70
references.pmid: 19812383
references.citation: Biol Blood Marrow Transplant. 2010 Apr;16(4):555-9
references.pmid: 20005966
references.citation: Am J Hematol. 2013 Feb;88(2):141-50
references.pmid: 23349007
references.citation: Biol Blood Marrow Transplant. 2007 Jan;13(1 Suppl 1):64-72
references.pmid: 17222772
references.citation: Blood. 2011 Mar 31;117(13):3641-7
references.pmid: 21156844
references.citation: Leuk Lymphoma. 2002 Jul;43(7):1409-14
references.pmid: 12389621
references.citation: Lancet. 2005 Mar 19-25;365(9464):1054-61
references.pmid: 15781101
references.citation: Science. 2001 Aug 3;293(5531):876-80
references.pmid: 11423618
references.citation: Nature. 1973 Jun 1;243(5405):290-3
references.pmid: 4126434
references.citation: Blood. 2011 Mar 31;117(13):3494-504
references.pmid: 21200024
references.citation: Blood. 2011 Nov 17;118(20):5697-700
references.pmid: 21926354
references.citation: Biol Blood Marrow Transplant. 2012 Sep;18(9):1446-54
references.pmid: 22449610
references.citation: Blood. 2010 Mar 11;115(10):1880-5
references.pmid: 19965667
references.citation: Blood. 2002 Feb 1;99(3):840-9
references.pmid: 11806985
references.citation: Bone Marrow Transplant. 2010 Oct;45(10):1502-7
references.pmid: 20098454
references.citation: Blood. 2005 Feb 1;105(3):973-7
references.pmid: 15388582
references.citation: Bone Marrow Transplant. 2010 Nov;45(11):1587-93
references.pmid: 20154739
references.citation: Haematologica. 2006 Apr;91(4):513-21
references.pmid: 16533723
references.citation: Haematologica. 2011 Mar;96(3):375-83
references.pmid: 21109693
references.citation: Blood. 2007 Jun 1;109(11):4686-92
references.pmid: 17317858
references.citation: Blood. 2013 Apr 4;121(14):2725-33
references.pmid: 23361905
references.citation: Postgrad Med. 2013 Jan;125(1):128-35
references.pmid: 23391678
references.citation: J Clin Oncol. 2011 Feb 1;29(4):392-7
references.pmid: 21149668
references.citation: Hematology Am Soc Hematol Educ Program. 2011;2011:250-6
references.pmid: 22160042
references.citation: Am J Hematol. 2012 Jun;87(6):610-9
references.pmid: 22615103
references.citation: Ann Hematol. 2009 Dec;88(12):1237-47
references.pmid: 19319532
references.citation: Ann Med. 2008;40(6):444-55
references.pmid: 18608121
references.citation: Bone Marrow Transplant. 2012 Apr;47(4):535-41
references.pmid: 21743499
references.citation: Lancet. 1998 Oct 3;352(9134):1087-92
references.pmid: 9798583
references.citation: Bone Marrow Transplant. 2010 Mar;45(3):458-63
references.pmid: 19718055
references.citation: Cancer. 2009 Sep 1;115(17):3842-7
references.pmid: 19472396
references.citation: Biol Blood Marrow Transplant. 2011 Jun;17(6):908-15
references.pmid: 20932924
references.citation: Blood. 2007 Feb 1;109(3):1316-21
references.pmid: 17018857
references.citation: Curr Hematol Malig Rep. 2008 Jan;3(1):31-6
references.pmid: 20425444
references.citation: Br J Haematol. 2011 Apr;153(2):149-67
references.pmid: 21401573
references.citation: Hematology Am Soc Hematol Educ Program. 2011;2011:222-30
references.pmid: 22160038
references.citation: Blood. 2012 Aug 16;120(7):1367-79
references.pmid: 22700718
references.citation: Blood. 2006 Aug 15;108(4):1421-3
references.pmid: 16601247